Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in INTELLIA THERAPEUTICS INC
BNP PARIBAS FINANCIAL MARKETS holds 591,277 shares of NTLA (INTELLIA THERAPEUTICS INC), worth $5.3M as of 2025-Q4. The position was increased (++1076.7% shares). NTLA represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$5.3M
Current Shares
591,277
Total Value Change
+$2.4M
Total Shares Change
+460,266
Other major holders of NTLA: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 591,277 |
+1076.7% |
| $5.3M |
| 0.0% |
| $9.06 |
44 |
| 2025-Q3 | Decreased | 50,251 | -88.2% | $867,835 | 0.0% | $16.92 | 0 |
| 2025-Q2 | Increased | 426,667 | +25.3% | $4M | 0.0% | $9.56 | 33 |
| 2025-Q1 | Decreased | 340,457 | -22.4% | $2.4M | 0.0% | $8.07 | 0 |
| 2024-Q4 | Increased | 438,458 | +78.0% | $5.1M | 0.0% | $11.41 | 41 |
| 2024-Q3 | Increased | 246,362 | +88.0% | $5.1M | 0.0% | $21.00 | 42 |
| 2024-Q2 | Increased | 131,011 | +75.8% | $2.9M | 0.0% | $22.38 | 40 |